IDEXX Laboratories

YTD

ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

CEO

Michael Erickson

CEOMichael Erickson

Employees

11,000

Employees11,000

Headquarters

Westbrook, Maine

HeadquartersWestbrook, Maine

Founded

1983

Founded1983

Employees

11,000

Employees11,000

IDXX Key Statistics

Market cap

40.98B

Market cap40.98B

Price-Earnings ratio

36.69

Price-Earnings ratio36.69

Dividend yield

—

Dividend yield—

Average volume

519.63K

Average volume519.63K

High today

$524.12

High today$524.12

Low today

$518.47

Low today$518.47

Open price

$522.89

Open price$522.89

Volume

31.87K

Volume31.87K

52 Week high

$769.98

52 Week high$769.98

52 Week low

$500.61

52 Week low$500.61

Stock Snapshot

With a market cap of 40.98B, IDEXX Laboratories(IDXX) trades at $520.21. The stock has a price-to-earnings ratio of 36.69.

During the trading session on 2026-09-24, IDEXX Laboratories(IDXX) shares reached a daily high of $524.12 and a low of $518.47. At a current price of $520.21, the stock is +0.3% higher than the low and still -0.7% under the high.

Trading volume for IDEXX Laboratories(IDXX) stock has reached 31.87K, versus its average volume of 519.63K.

The stock's 52-week range extends from a low of $500.61 to a high of $769.98.

IDXX News

Simply Wall St 8h

IDEXX Laboratories Could Be 26% Undervalued Following UK Faecal Dx Expansion - simplywall.st

...

Nasdaq 23h

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical Systems INSP appears positioned for solid growth over the next few quarters as it navigates a significant product transition. Management highlig...

Nasdaq 4d

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference

IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing deman...

Analyst ratings

53%

of 17 ratings

Buy

52.9%

Hold

41.2%

Sell

5.9%

More IDXX News

Simply Wall St 5d

Should Faecal Dx Expansion Require Action From IDEXX Stock Investors?

IDEXX Laboratories expanded its Faecal Dx antigen testing platform in the UK to include taeniid tapeworms, adding broader parasite coverage, automatic Echinococ...

Simply Wall St 7d

What Is IDEXX Laboratories Gaining From Its Move Into Veterinary AI?

IDEXX Laboratories (NasdaqGS: IDXX) has acquired veterinary AI software firm CoVetAI to expand its diagnostic and workflow tools. The deal brings ambient liste...

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.